NHLBI Grant: Planning Innovative Late-Phase Clinical Trials
SynopsisVersion HistoryRelated DocumentsPackage The National Heart, Lung, and Blood Institute (NHLBI) is offering this grant to support planning activities for late-phase (Phase II and beyond) investigator-initiated clinical trials. This grant is for studies addressing critical clinical questions aligned with NHLBI's mission, specifically those requiring innovative or non-traditional clinical trial designs and statistical analysis plans. The funding aims to facilitate the development of feasible and well-designed single or multi-site trials. Grantees will [...]